José Antonio López-López
Research Subjects
José Antonio López-López has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Pedro Sánchez-Rovira
Department of Medical Oncology, Complejo Hospitalario de Jaén, 23007 Jaén, Spain
3 shared publications - Antonio José Cabrera-Serrano
Genomic Oncology Area, Centre for Genomics and Oncological Research, University of Granada, Andalusian Regional Government, 18016, Granada, Spain, Spain
2 shared publications - Carmen González-Olmedo
Medical Oncology Unit, University Hospital of Jaén, 23007 Jaén, Spain, Spain
2 shared publications - Fernando Jesús Reyes Zurita
Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, 18071 Granada, Spain
2 shared publications - Francisco José García-Verdejo
Department of Medical Oncology, Complejo Hospitalario de Jaén, 23007 Jaén, Spain
2 shared publications - Juan Francisco Gutiérrez-Bautista
Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain
2 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by MDPI AG in Preprints.org
Autophagy-Related Genetic Variants Influence Prostate Cancer Susceptibility and Are Associated with Immune and Inflammatory Phenotypes
Background: Autophagy maintains cellular homeostasis and has context-dependent roles in prostate cancer (PCa). We investigated whether common variation in autophagy-related genes influences PCa susceptibility. Methods: We meta-analyzed UK Biobank and FinnGen genome-wide association study (GWAS) datasets, including 17,583 cases and 279,188 controls. Among 50,020 shared variants, 16 were prioritized, and 13 were evaluated in a Spanish cohort (218 cases and 468 controls). Functional analyses were conducted in two Human Functional Genomics Project (HFGP) cohorts (500FG and 300OB) and complemented by in silico molecular quantitative trait locus (QTL) analyses. Results: In the overall meta-analysis, TNFSF10-rs7631904 showed the strongest association (OR = 1.07, P = 4.92×10-7). ARNT-rs72992015 was associated with PCa risk in Spain (OR = 2.09, P = 5.55×10-3) and overall (OR = 1.07, P = 2.80×10-6), with between-cohort heterogeneity (Phet = 0.01). ARNT-rs72992015 was associated with circulating VEGF concentrations in healthy participants (P = 7.86×10-4) and TNFSF10-rs7631904 was associated with the monocyte-to-lymphocyte ratio (P = 8.81×10-4), circulating EN-RAGE (P = 2.85×10-3), and cathepsin L concentrations (P = 8.34×10-3) in obese participants. Prostate eQTL analyses linked VAMP3, ARNT and MAP1LC3A variants to VAMP3, CTSS and MAP1LC3A expression, respectively. Conclusions: These findings identify autophagy-related susceptibility signals with exploratory immune, inflammatory, and regulatory associations. Genetic replication, colocalization analyses, and experimental validation are needed to establish their functional relevance.
- 16 October 2026
- Published by MDPI AG in Preprints.org
Open AccessAutophagy-Related Genetic Variants Influence Prostate Cancer Susceptibility and Are Associated with Immune and Inflammatory Phenotypes
Background: Autophagy maintains cellular homeostasis and has context-dependent roles in prostate cancer (PCa). We investigated whether common variation in autophagy-related genes influences PCa susceptibility. Methods: We meta-analyzed UK Biobank and FinnGen genome-wide association study (GWAS) datasets, including 17,583 cases and 279,188 controls. Among 50,020 shared variants, 16 were prioritized, and 13 were evaluated in a Spanish cohort (218 cases and 468 controls). Functional analyses were conducted in two Human Functional Genomics Project (HFGP) cohorts (500FG and 300OB) and complemented by in silico molecular quantitative trait locus (QTL) analyses. Results: In the overall meta-analysis, TNFSF10-rs7631904 showed the strongest association (OR = 1.07, P = 4.92×10-7). ARNT-rs72992015 was associated with PCa risk in Spain (OR = 2.09, P = 5.55×10-3) and overall (OR = 1.07, P = 2.80×10-6), with between-cohort heterogeneity (Phet = 0.01). ARNT-rs72992015 was associated with circulating VEGF concentrations in healthy participants (P = 7.86×10-4) and TNFSF10-rs7631904 was associated with the monocyte-to-lymphocyte ratio (P = 8.81×10-4), circulating EN-RAGE (P = 2.85×10-3), and cathepsin L concentrations (P = 8.34×10-3) in obese participants. Prostate eQTL analyses linked VAMP3, ARNT and MAP1LC3A variants to VAMP3, CTSS and MAP1LC3A expression, respectively. Conclusions: These findings identify autophagy-related susceptibility signals with exploratory immune, inflammatory, and regulatory associations. Genetic replication, colocalization analyses, and experimental validation are needed to establish their functional relevance.
- Open Access
- 6 October 2026
- Published by MDPI AG in Preprints.org
Effectiveness of a Music Therapy Intervention in Cancer Patients Under Active Treatment at the University Hospital of Jaén: A Non-Randomized Controlled Trial
Introduction: The diagnosis and evolution of cancer generate a multidimensional impact (physical, psychological, emotional, social, and spiritual) on the patient. Some active treatments entail long stays in the day hospital, which can deteriorate patients' quality of life. Objective: To analyze the effectiveness of a live music session in cancer patients under active treatment. Specifically, its impact on anxiety, treatment-related symptoms, satisfaction, and perception of session duration was assessed. Method: A non-randomized controlled trial of two parallel arms with pre-post measurement was conducted in patients with active intravenous cancer treatment at the University Hospital of Jaén (n = 125; GI = 60; CG = 65). Results: The findings reflect that the intervention group significantly reduced the need for nursing care (OR = 0.89; 95% CI: 0.82 - 0.97) and perceived that the treatment proceeded faster (OR = 4.60; 95% CI: 1.80 - 11.79). Likewise, the assessment that the infusion was more enjoyable was significantly higher in the intervention group compared to the control group (3.78 ± 0.98 vs. 3.08 ± 0.71; p < 0.001). No significant differences in anxiety were achieved. Conclusion: A single live music session makes the treatment be perceived as shorter and more enjoyable; in addition to a favorable clinical trend toward better tolerance of cancer treatment.
- 6 October 2026
- Published by MDPI AG in Preprints.org
Open AccessEffectiveness of a Music Therapy Intervention in Cancer Patients Under Active Treatment at the University Hospital of Jaén: A Non-Randomized Controlled Trial
Introduction: The diagnosis and evolution of cancer generate a multidimensional impact (physical, psychological, emotional, social, and spiritual) on the patient. Some active treatments entail long stays in the day hospital, which can deteriorate patients' quality of life. Objective: To analyze the effectiveness of a live music session in cancer patients under active treatment. Specifically, its impact on anxiety, treatment-related symptoms, satisfaction, and perception of session duration was assessed. Method: A non-randomized controlled trial of two parallel arms with pre-post measurement was conducted in patients with active intravenous cancer treatment at the University Hospital of Jaén (n = 125; GI = 60; CG = 65). Results: The findings reflect that the intervention group significantly reduced the need for nursing care (OR = 0.89; 95% CI: 0.82 - 0.97) and perceived that the treatment proceeded faster (OR = 4.60; 95% CI: 1.80 - 11.79). Likewise, the assessment that the infusion was more enjoyable was significantly higher in the intervention group compared to the control group (3.78 ± 0.98 vs. 3.08 ± 0.71; p < 0.001). No significant differences in anxiety were achieved. Conclusion: A single live music session makes the treatment be perceived as shorter and more enjoyable; in addition to a favorable clinical trend toward better tolerance of cancer treatment.
- Open Access
- 3 January 2025
- Published by MDPI AG in Preprints.org
Crosstalk Between Autophagy and Oxidative Stress in Hematological Malignancies: Mechanisms, Implications, and Therapeutic Potential
Autophagy is a fundamental cellular process that maintains homeostasis by degrading damaged components and regulating stress responses. It plays a crucial role in cancer biology, including tumor progression, metastasis, and therapeutic resistance. Oxidative stress, similarly, is key to maintaining cellular balance by regulating oxidants and antioxidants, with its disruption leading to molecular damage. The interplay between autophagy and oxidative stress is particularly significant, as reactive oxygen species (ROS) act as both inducers and by-products of autophagy. While autophagy can function as a tumor suppressor in early cancer stages, it often shifts to a pro-tumorigenic role in advanced disease, aiding cancer cell survival under adverse conditions such as hypoxia and nutrient deprivation. This dual role is mediated by several signaling pathways, including PI3K/AKT/mTOR, AMPK, and HIF-1α, which coordinate the balance between autophagic activity and ROS production. In this review, we explore the mechanisms by which autophagy and oxidative stress interact across different hematological malignancies. We discuss how oxidative stress triggers autophagy, creating a feedback loop that promotes tumor survival, and how autophagic dysregulation leads to increased ROS accumulation, exacerbating tumorigenesis. We also examine the therapeutic implications of targeting the autophagy-oxidative stress axis in cancer. Current strategies involve modulating autophagy through specific inhibitors, enhancing ROS levels with pro-oxidant compounds, and combining these approaches with conventional therapies to overcome drug resistance. Understanding the complex relationship between autophagy and oxidative stress provides critical insights into novel therapeutic strategies aimed at improving cancer treatment outcomes.
- 3 January 2025
- Published by MDPI AG in Preprints.org
Open AccessCrosstalk Between Autophagy and Oxidative Stress in Hematological Malignancies: Mechanisms, Implications, and Therapeutic Potential
Autophagy is a fundamental cellular process that maintains homeostasis by degrading damaged components and regulating stress responses. It plays a crucial role in cancer biology, including tumor progression, metastasis, and therapeutic resistance. Oxidative stress, similarly, is key to maintaining cellular balance by regulating oxidants and antioxidants, with its disruption leading to molecular damage. The interplay between autophagy and oxidative stress is particularly significant, as reactive oxygen species (ROS) act as both inducers and by-products of autophagy. While autophagy can function as a tumor suppressor in early cancer stages, it often shifts to a pro-tumorigenic role in advanced disease, aiding cancer cell survival under adverse conditions such as hypoxia and nutrient deprivation. This dual role is mediated by several signaling pathways, including PI3K/AKT/mTOR, AMPK, and HIF-1α, which coordinate the balance between autophagic activity and ROS production. In this review, we explore the mechanisms by which autophagy and oxidative stress interact across different hematological malignancies. We discuss how oxidative stress triggers autophagy, creating a feedback loop that promotes tumor survival, and how autophagic dysregulation leads to increased ROS accumulation, exacerbating tumorigenesis. We also examine the therapeutic implications of targeting the autophagy-oxidative stress axis in cancer. Current strategies involve modulating autophagy through specific inhibitors, enhancing ROS levels with pro-oxidant compounds, and combining these approaches with conventional therapies to overcome drug resistance. Understanding the complex relationship between autophagy and oxidative stress provides critical insights into novel therapeutic strategies aimed at improving cancer treatment outcomes.